The selective μ opioid receptor antagonist β-funaltrexamine attenuates methamphetamine-induced stereotypical biting in mice

Brain Research

Volumn 1522, Issue , 2013, Pages 88-98

  Kitanaka, Junichi ^a   Kitanaka, Nobue ^a   Hall, F Scott ^b   Uhl, George R ^b   Fukushima, Yuko ^a   Sawai, Tatsuo ^a   Watabe, Kaname ^c   Kubo, Hitoshi ^c   Takahashi, Hitoshi ^c   Tanaka, Koh Ichi ^a   Nishiyama, Nobuyoshi ^a   Tatsuta, Tomohiro ^d   Morita, Yoshio ^e   Takemura, Motohiko ^a  

^a HYOGO COLLEGE OF MEDICINE   (Japan)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c Technical Department   (Japan)

^d Ibogawa Hospital   (Japan)

^e BAIKA WOMEN'S UNIVERSITY   (Japan)

Author keywords

Opioid receptor; Endogenous opioid system; Methamphetamine; Stereotypical behavior

Indexed keywords

BETA FUNALTREXAMINE; METHAMPHETAMINE; NALOXONE; NALTRINDOLE; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BITE; COMPULSION; CONTROLLED STUDY; EXPERIMENTAL RAT; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STEREOTYPY; TREATMENT RESPONSE;

ANIMALS; BEHAVIOR, ANIMAL; CENTRAL NERVOUS SYSTEM STIMULANTS; MALE; METHAMPHETAMINE; MICE; MICE, INBRED ICR; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID, MU; STEREOTYPED BEHAVIOR;

MUS;

EID: 84879798686     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2013.05.027     Document Type: Article

References (38)

1. K. Anggadiredja, K. Sakimura, T. Hiranita, and T. Yamamoto Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward Brain Res. 1021 2004 272 276
2. P.S. Brocardo, J. Budni, K.R. Lobato, A.R. Santos, and A.L. Rodrigues Evidence for the involvement of the opioid system in the antidepressant-like effect of folic acid in the mouse forced swimming test Behav. Brain Res. 200 2009 122 127
3. A. Campillo, D. Cabanero, A. Romero, P. Garcia-Nogales, and M.M. Puig Delayed postoperative latent pain sensitization revealed by the systemic administration of opioid antagonists in mice Eur. J. Pharmacol. 657 2011 89 96
4. C.C. Chien, Y.J. Lee, L.W. Fan, I.K. Ho, and L.T. Tien Naloxonazine, a specific mu-opioid receptor antagonist, attenuates the increment of locomotor activity induced by acute methamphetamine in mice Toxicol. Lett. 212 2012 61 65
5. C.T. Chiu, T. Ma, and I.K. Ho Attenuation of methamphetamine-induced behavioral sensitization in mice by systemic administration of naltrexone Brain Res. Bull. 67 2005 100 109
6. B. Costall, C.D. Marsden, R.J. Naylor, and C.J. Pycock Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei Brain Res. 123 1977 89 111
7. M. Cretzmeyer, M.V. Sarrazin, D.L. Huber, R.I. Block, and J.A. Hall Treatment of methamphetamine abuse: research findings and clinical directions J. Subst. Abuse Treat. 24 2003 267 277
8. J.M. Delfs, and A.E. Kelley The role of D1 and D2 dopamine receptors in oral stereotypy induced by dopaminergic stimulation of the ventrolateral striatum Neuroscience 39 1990 59 67
9. S. Desjardins, C. Doyen, Y. Contejean, K. Kaye, and P. Paubel Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form Encephale-Revue De Psychiatr. Clin. Biol. Ther. 35 2009 168 172
10. M.A. Gerrits, H.B. Lesscher, and J.M. van Ree Drug dependence and the endogenous opioid system Eur. Neuropsychopharmacol. 13 2003 424 434
11. C. Gianoulakis Endogenous opioids and addiction to alcohol and other drugs of abuse Curr. Top. Med. Chem. 4 2004 39 50
12. G. Gianutsos, G. Morrow, S. Light, and M.J. Sweeney Dopaminergic properties of nomifensine Pharmacol. Biochem. Behav. 17 1982 951 954
13. S.B. Greberman, and K. Wada Social and legal factors related to drug abuse in the United States and Japan Public Health Rep. 109 1994 731 737
14. J. Haggkvist, S. Lindholm, and J. Franck The opioid receptor antagonist naltrexone attenuates reinstatement of amphetamine drug-seeking in the rat Behav. Brain Res. 197 2009 219 224
15. J. Haggkvist, C. Bjorkholm, P. Steensland, S. Lindholm, J. Franck, and B. Schilstrom Naltrexone attenuates amphetamine-induced locomotor sensitization in the rat Addict. Biol. 16 2011 20 29
16. K.A. Horner, E.S. Noble, and Y.E. Gilbert Methamphetamine-induced stereotypy correlates negatively with patch-enhanced prodynorphin and arc mRNA expression in the rat caudate putamen: the role of mu opioid receptor activation Pharmacol. Biochem. Behav. 95 2010 410 421
17. K.A. Horner, J.C. Hebbard, A.S. Logan, G.A. Vanchipurakel, and Y.E. Gilbert Activation of mu opioid receptors in the striatum differentially augments methamphetamine-induced gene expression and enhances stereotypic behavior J. Neurochem. 120 2012 779 794
18. L. Karila, A. Weinstein, H.J. Aubin, A. Benyamina, M. Reynaud, and S.L. Batki Pharmacological approaches to methamphetamine dependence: a focused review Br. J. Clin. Pharmacol. 69 2010 578 592
19. A.E. Kelley, C.G. Lang, and A.M. Gauthier Induction of oral stereotypy following amphetamine microinjection into a discrete subregion of the striatum Psychopharmacology (Berl) 95 1988 556 559
20. B.L. Kieffer, and C. Gaveriaux-Ruff Exploring the opioid system by gene knockout Prog. Neurobiol. 66 2002 285 306
21. 1 receptor antagonists determine the behavioral pattern of the methamphetamine-induced stereotypy in mice Psychopharmacology (Berl) 203 2009 781 792
22. J. Kitanaka, N. Kitanaka, F.S. Hall, G.R. Uhl, H. Asano, R. Chatani, S. Hayata, H. Yokoyama, K. Tanaka, N. Nishiyama, and M. Takemura Pretreatment with nomifensine or nomifensine analogue 4-phenyl-1,2,3,4-tetrahydroisoquinoline augments methamphetamine-induced stereotypical behavior in mice Brain Res. 1439 2012 15 26
23. 1 receptor antagonist in combination with methamphetamine. Brain Res. 1482 2012 40 46
24. N. Kitanaka, J. Kitanaka, and M. Takemura Inhibition of methamphetamine-induced hyperlocomotion in mice by clorgyline, a monoamine oxidase-a inhibitor, through alteration of the 5-hydroxytryptamine turnover in the striatum Neuroscience 130 2005 295 308
25. P. Leone, D. Pocock, and R.A. Wise Morphine-dopamine interaction: ventral tegmental morphine increases nucleus accumbens dopamine release Pharmacol. Biochem. Behav. 39 1991 469 472
26. D.S. Mathon, L.J. Vanderschuren, and G.M. Ramakers Reduced psychostimulant effects on dopamine dynamics in the nucleus accumbens of μ-opioid receptor knockout mice Neuroscience 141 2006 1679 1684
27. B.L. Odlaug, and J.E. Grant Pathologic skin picking Am. J. Drug Alcohol Abuse 36 2010 296 303
28. S.W. Park, X. Shen, L.T. Tien, R. Roman, and T. Ma Methamphetamine- induced changes in the striatal dopamine pathway in mu-opioid receptor knockout mice J. Biomed. Sci. 18 2011 83
29. J.T. Rapp, and T.R. Vollmer Stereotypy II: a review of neurobiological interpretations and suggestions for an integration with behavioral methods Res. Dev. Disabil. 26 2005 548 564
30. T.E. Robinson, and J.B. Becker Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis Brain Res. 396 1986 157 198
31. A.S. Roth, R.B. Ostroff, and R.E. Hoffman Naltrexone as a treatment for repetitive self-injurious behavior: an open-label trial J. Clin. Psychiatry 57 1996 233 237
32. X. Shen, C. Purser, L.T. Tien, C.T. Chiu, I.A. Paul, R. Baker, H.H. Loh, I.K. Ho, and T. Ma mu-Opioid receptor knockout mice are insensitive to methamphetamine-induced behavioral sensitization J. Neurosci. Res. 88 2010 2294 2302
33. J. Stewart Reinstatement of heroin and cocaine self-administration behavior in the rat by intracerebral application of morphine in the ventral tegmental area Pharmacol. Biochem. Behav. 20 1984 917 923
34. T. Tatsuta, N. Kitanaka, J. Kitanaka, Y. Morita, and M. Takemura Lobeline attenuates methamphetamine-induced stereotypy in adolescent mice Neurochem. Res. 31 2006 1359 1369
35. T. Tatsuta, N. Kitanaka, J. Kitanaka, Y. Morita, and M. Takemura Lack of effect of anticonvulsant topiramate on methamphetamine-induced stereotypy and rewarding property in mice Pharmacol. Biochem. Behav. 87 2007 48 55
36. H. Ujike, and M. Sato Clinical features of sensitization to methamphetamine observed in patients with methamphetamine dependence and psychosis Ann. N.Y. Acad. Sci. 1025 2004 279 287
37. S.J. Ward, P.S. Portoghese, and A.E. Takemori Pharmacological characterization in vivo of the novel opiate, β-funaltrexamine J. Pharmacol. Exp. Ther. 220 1982 494 498
38. S.H.N. Willemsenswinkels, J.K. Buitelaar, G.J. Nijhof, and H. Vanengeland Failure of naltrexone hydrochloride to reduce self-injurious and autistic behavior in mentally-retarded adults - double-blind placebo-controlled studies Arch. Gen. Psychiatry 52 1995 766 773